Related Experiment Video
Updated: Jun 24, 2026
07:47
Design and Evaluation of Smart Glasses for Food Intake and Physical Activity Classification
Published on: February 14, 2018
11.3K
A Peek Under the Hood: Explaining the MiniMed™ 780G Algorithm with Meal Detection Technology.
Benyamin Grosman1, Anirban Roy1, Louis Lintereur1
1Medtronic Diabetes, Northridge, California, USA.
Diabetes Technology & Therapeutics
|February 20, 2024
Summary
The MiniMed™ 780G system, an advanced diabetes management technology, has shown proven safety and effectiveness. Using recommended settings significantly improves glycemic control, simplifying daily diabetes care for users.
Area of Science:
- Endocrinology and Diabetes Technology
Background:
- The MiniMed™ 780G system represents a significant advancement in automated insulin delivery (AID) technology.
- Regulatory approvals, including CE mark (June 2020) and FDA approval (April 2023), underscore its market readiness and validation.
Purpose of the Study:
- To detail the iterative development process of the MiniMed™ 780G system's sophisticated algorithm.
- To elucidate how this advanced technology simplifies diabetes management for individuals.
Main Methods:
- Review of clinical trial data and real-world evidence assessing the safety and effectiveness of the MiniMed™ 780G system.
- Analysis of the algorithm's design evolution and its impact on user experience.
Main Results:
- Clinical studies and real-world analyses confirm the safety and effectiveness of the MiniMed™ 780G system.
- Demonstrated improvement in glycemic outcomes, specifically time in range, when utilizing the system's recommended settings.
Conclusions:
- The MiniMed™ 780G system offers a safe and effective solution for diabetes management.
- The iterative development has resulted in a user-friendly technology that enhances glycemic control and simplifies the daily burden of diabetes.
